Advertisement

Topics

Bristol-Myers Squibb Company and Pfizer Company Profile

20:30 EDT 19th September 2017 | BioPortfolio

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an investigational oral anticoagulant discovered by Bristol-Myers Squibb being studied for the prevention and treatment of a broad range of venous and arterial thrombotic conditions. This global alliance combines Bristol-Myers Squibb's long-standing strengths in cardiovascular drug development and commercialization with Pfizer’s global scale and expertise in this field to maximize the potential benefits of apixaban for patients.


News Articles [1930 Associated News Articles listed on BioPortfolio]

Better Buy: Pfizer Inc. vs. Bristol-Myers Squibb

But the two big pharma companies are enemies in the oncology and immunology arenas. How do these collaborators and competitors compare for investors? Here's how Pfizer and Bristol-Myers Squibb sta...

Bristol-Myers Squibb and QIAGEN collaborate

Bristol-Myers Squibb Company and QIAGEN have signed an agreement to explore the use of next-generation sequencing (NGS) technology to develop gene expression profiles (GEPs) as  predictive or prognos...

Bristol-Myers, Pfizer Report Investigational Eliquis Data

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) reported findings from EMANATE, a Phase 4 clinical trial. The descriptive, randomized, open-label trial explored ...

What About A Bristol-Myers Squibb Takeover By Pfizer?

The acquisition could likely be financed without many problems and would be accretive for Pfizer's owners from the beginning. Pfizer has a history of making big acquisitions, and has access to ver...

Bristol-Myers To Sell Manufacturing Facility In Swords, Ireland

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and SK Biotek Co. Ltd. announced a purchase agreement to sell Bristol-Myers Squibb's small molecule active pharmaceutical ingredient ma...

Bristol-Myers Squibb To Acquire IFM Therapeutics

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and IFM Therapeutics announced the companies have signed an agreement under which Bristol-Myers Squibb will acquire all of the outstand...

Bristol-Myers & Seattle Genetics To Evaluate Combination Of Opdivo And ADCETRIS

NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and Seattle Genetics, Inc. (SGEN) announced a collaboration agreement to evaluate the combination of Bristol-Myers Squibb's immunothera...

Bristol-Myers Squibb to Acquire IFM Therapeutics, Strengthening its Oncology Pipeline Focus on Innate Immunity

NEW YORK & BOSTON–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) and IFM Therapeutics (IFM) announced today that the companies have signed a definitive agreement under which B...

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

A Systematic Review and Pooled Analysis of Select Safety Parameters Among Normal Healthy Volunteers Taking Placebo in Phase 1 Clinical Trials.

A systematic review of the Bristol-Myers Squibb normal healthy volunteers (NHVs) database identified phase 1 trials that included NHVs administered placebo with the aim of characterizing normal inter-...

U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab.

On December 22, 2014, the U. S. Food and Drug Administration (FDA) granted accelerated approval to nivolumab (OPDIVO®, Bristol-Myers Squibb) for the treatment of patients with unresectable or metasta...

In Reply to Myers et al.

Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2.

Bristol stool form 1 and 2 is an important predictor of inadequate bowel preparation.

Sharing is Caring: The Case for Company-Level Collaboration in Pharmacoeconomic Modelling.

Clinical Trials [197 Associated Clinical Trials listed on BioPortfolio]

Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Glucophage®, Bristol-Myers Squibb Company) in Fed, Healthy, Adult Subjects

- Objective: - A Randomized, Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Metformin HCl (1000 mg), Co...

Bioequivalence Study of Cefprozil Tablets, USP 500 mg Undef Fed Conditions

The objective of this study is to assess the single - dose relative bioavailability of Ranbaxy and Bristol-Myers Squibb Company (CEFZIL ®) 500 mg cefprozil tablets, under fed conditions.

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

This study compared the relative bioavailability (rate and extent of absorption) of Pravastatin Sodium Tablets 80 mg by Teva Pharmaceutical Industries, Ltd. with that of Pravachol® Tablet...

Companies [1565 Associated Companies listed on BioPortfolio]

Bristol-Myers Squibb Company & Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize ELIQUIS, an investigational oral anticoagulant discovered by Bristol-M...

Bristol-Myers Squibb Company and Pfizer Inc.

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize Eliquis, an oral anticoagulant discovered by Bristol-Myers Squibb. Thi...

Pfizer Inc. & Bristol-Myers Squibb

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb and Pfizer

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an oral anticoagulant discovered by Bristol-Myers Squibb. Th...

Bristol-Myers Squibb Company and Pfizer

In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an investigational oral anticoagulant discovered by Bristol-...

More Information about "Bristol-Myers Squibb Company and Pfizer" on BioPortfolio

We have published hundreds of Bristol-Myers Squibb Company and Pfizer news stories on BioPortfolio along with dozens of Bristol-Myers Squibb Company and Pfizer Clinical Trials and PubMed Articles about Bristol-Myers Squibb Company and Pfizer for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bristol-Myers Squibb Company and Pfizer Companies in our database. You can also find out about relevant Bristol-Myers Squibb Company and Pfizer Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record